Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

Adv Pharm Bull. 2023;13(4): 646-662. doi: 10.34172/apb.2023.070

PMID: 38022807 PMCID: PMC10676549

Review Article

Nanotechnology-Based Drug Delivery Systems in the Transdermal Treatment of Melanoma

Zahra Saeidi ¹ , Rashin Giti ², Mehdi Rostami ¹, Farhad Mohammadi ¹ *

Cited by CrossRef: 2

1- Zakharova L, Maganova F, Sinyashin K, Gaynanova G, Mirgorodskaya A, Vasilieva E, Sinyashin O. Supramolecular Strategy for the Design of Nanocarriers for Drugs and Natural Bioactives: Current State of the Art (A Review). Russ J Gen Chem. 2023;93(7):1867 [Crossref]

2- Liu H, Gou X, Tan Y, Fan Q, Chen J. Immunotherapy and delivery systems for melanoma. Human Vaccines & Immunotherapeutics. 2024;20(1) [Crossref]

3- Zhang Y, Liu X, Wu G. Advances in mechanisms and challenges in clinical translation of synergistic nanomaterial-based therapies for melanoma. Front Cell Dev Biol. 2025;13 [Crossref]

4- Nagashree D, Deepika A, Shabnam D, Naveen N. Cubosomes as smart nanocarriers in targeted therapy of skin cancer and cosmetic delivery systems. Nano-Structures & Nano-Objects. 2026;46:101681 [Crossref]

5- Santos A, Santana Júnior C, Rocha L, Sitarek P, Baranger K, Picot L, Serafini M. New horizons for an old challenge: an exploratory review on the antimelanoma effect of inclusion complexes. Journal of Drug Delivery Science and Technology. 2026;123:108475 [Crossref]

6- Narula H, Devi N, Singh T, Kumar P, Dhiman S, Dora C. Unleashing the Potential of Cubosomes to Overcome Ocular Barriers in Precision Drug Delivery. Advanced Therapeutics. 2025;8(12) [Crossref]

7- Plewa P, Ćmil M, Lewandowski F, Poniewierska-Baran A, Pawlik A. mRNA Vaccines in Melanoma Immunotherapy—A Narrative Review. Cells. 2026;15(3):298 [Crossref]

8- Nunes F, Viana A, Salles T, Aytar E, Vianna Santos R, Nassan M, Abdou S, Aldawsari N, Mortari S, Bohn Rhoden C. Reduced graphene oxide as a potential anticancer nanomaterial: in vitro activity against melanoma and glioblastoma combined with molecular docking insights . Journal of Toxicology and Environmental Health, Part A. 2026;:1 [Crossref]